T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$3.3B |
| 2 |
Eli Lilly
LLY
|
+$2.75B |
| 3 |
AstraZeneca
AZN
|
+$1.98B |
| 4 |
Coupang
CPNG
|
+$1.54B |
| 5 |
Fortinet
FTNT
|
+$1.48B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NXP Semiconductors
NXPI
|
+$2.34B |
| 2 |
Morgan Stanley
MS
|
+$2.26B |
| 3 |
Airbnb
ABNB
|
+$2.04B |
| 4 |
Qualcomm
QCOM
|
+$1.95B |
| 5 |
NVIDIA
NVDA
|
+$1.81B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.35% |
| 2 | Healthcare | 16.19% |
| 3 | Consumer Discretionary | 15.55% |
| 4 | Financials | 12.84% |
| 5 | Communication Services | 12.27% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
476
Equity Lifestyle Properties
ELS
$12.4B
| $263M | 0.03% |
4,128,158
+1,309,483
| +46% | +$81.5M |
|
|
MRTX
477
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
| $263M | 0.03% |
1,532,500
-26,916
| -2% | -$5.33M |
|
478
SS&C Technologies
SSNC
$18.8B
| $262M | 0.03% |
3,747,668
-3,631,894
| -49% | -$245M |
|
479
Seer Inc
SEER
$118M
| $261M | 0.03% |
5,441,702
+124,667
| +2% | +$7.29M |
|
480
Post Holdings
POST
$3.65B
| $261M | 0.03% |
3,770,248
-31,063
| -0.8% | -$2.04M |
|
481
Fate Therapeutics
FATE
$317M
| $260M | 0.03% |
3,149,106
-361,864
| -10% | -$34.7M |
|
482
Repligen
RGEN
$9.35B
| $256M | 0.03% |
1,319,174
+130,709
| +11% | +$26.8M |
|
483
Landstar System
LSTR
$6.31B
| $256M | 0.03% |
1,550,041
-37,952
| -2% | -$5.9M |
|
484
Outset Medical
OM
$84.6M
| $256M | 0.03% |
313,290
+2,737
| +0.9% | +$2.11M |
|
485
Constellium
CSTM
$4B
| $255M | 0.03% |
17,362,553
-12,188
| -0.1% | -$175K |
|
|
ONC
486
BeOne Medicines Ltd
ONC
$40.6B
| $254M | 0.03% |
729,930
-107,448
| -13% | -$35.6M |
|
|
NEE.PRP
487
DELISTED
NextEra Energy, Inc. 5.279% Corporate Units
NEE.PRP
| $252M | 0.03% |
5,077,634
+117,658
| +2% | +$6.02M |
|
488
Boston Scientific
BSX
$74.5B
| $252M | 0.03% |
6,514,635
-7,747,002
| -54% | -$293M |
|
489
Citigroup
C
$231B
| $251M | 0.03% |
3,447,457
-214,811
| -6% | -$14.3M |
|
490
Southern Copper
SCCO
$165B
| $250M | 0.03% |
4,018,935
-3,425,538
| -46% | -$225M |
|
491
CALL
Invesco QQQ Trust
QQQ
$481B
| $250M | 0.03% |
781,900
+341,300
| +77% | +$109M |
|
492
Idacorp
IDA
$8.21B
| $249M | 0.02% |
2,489,417
+440,592
| +22% | +$40.3M |
|
493
PROG Holdings
PRG
$1.64B
| $248M | 0.02% |
5,732,770
-178,064
| -3% | -$8.89M |
|
494
Brown & Brown
BRO
$23.8B
| $248M | 0.02% |
5,426,866
+53,419
| +1% | +$2.45M |
|
495
Public Storage
PSA
$60.4B
| $247M | 0.02% |
1,000,959
-22,903
| -2% | -$5.33M |
|
496
Xencor
XNCR
$1.72B
| $245M | 0.02% |
5,699,661
+9,305
| +0.2% | +$441K |
|
497
Alexandria Real Estate Equities
ARE
$8.27B
| $244M | 0.02% |
1,484,170
+92,269
| +7% | +$15.4M |
|
498
Mattel
MAT
$4.19B
| $243M | 0.02% |
12,193,829
-1,104,123
| -8% | -$21.3M |
|
499
Reynolds Consumer Products
REYN
$5.53B
| $242M | 0.02% |
8,114,240
-102,069
| -1% | -$3.02M |
|
500
Lazard
LAZ
$4.24B
| $241M | 0.02% |
5,540,237
-1,918,286
| -26% | -$81.6M |
|
Similar funds
T. Rowe Price Associates's Q1 2021 Portfolio in Review
As of Q1 2021, T. Rowe Price Associates held 2,908 positions worth $999B, up 2.5% from $974B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2021 filing shows 248 new, 1,171 increased, 1,334 reduced and 66 closed positions. Its largest new stake was Coupang: 33,380,859 shares worth $1.63B. The largest sale was NXP Semiconductors, an estimated $2.34B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2021 buy was Coupang: 33,380,859 shares worth $1.63B.
- T. Rowe Price Associates added most to Zoom in Q1 2021, an estimated $3.3B increase.
- T. Rowe Price Associates's biggest Q1 2021 reduction was NXP Semiconductors, cutting an estimated $2.34B.
- T. Rowe Price Associates fully exited CONCHO RESOURCES INC. in Q1 2021, selling an estimated $205M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $999B portfolio in Q1 2021.
- T. Rowe Price Associates opened 248 new positions and closed 66 in Q1 2021.
- T. Rowe Price Associates's portfolio value rose 2.5% quarter-over-quarter to $999B.
Based on T. Rowe Price Associates's 13F filing for Q1 2021, filed 17 May 2021.